HeartSciences Inc.
HSCS
NASDAQ·Healthcare·Medical - Devices·Mkt cap $8.1M
$3.73
▲ +11.01%
P/E
—
Mkt Cap
$8.1M
52-Wk Range
$1.63–$3.83
52-Week Range
$1.63 - $3.83
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 12.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary AI algorithms for cardiac relaxation and dysfunction detection
- Hardware-agnostic cloud platform enabling broad integration
- First-mover advantage in AI-enhanced resting ECG diagnostics
- Non-invasive solution reducing healthcare costs versus alternative cardiac testing
Bear Case
1 risk
- Above-average volatility (beta 1.9).
Growth
Stable outlook
Rising global prevalence of heart disease and aging populations
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+102.7% over 3m
Quality
Mixed
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying HSCS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 10, 2026
JUL 23, 2026
Reported EPS of -$0.88 vs -$0.66 consensus (-33.3% surprise).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-33.3%
Revenue trend · last 8Q
—
—
—
—
—
—
—
-100%
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q4 26
Q3 26
$0
$0
$0
$4.3K
$1.9K
$2.4K
$0
$0
Margins · last 8Q
Gross
—
Profit
—
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Ascendiant Capital · Mar 24, 2026
vs Industry
How HSCS stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related